Complaint Reminds CVS: No Support For Memory Claim In Fish Oil Study
This article was originally published in The Tan Sheet
Executive Summary
A complaint filed by CSPI working with law firms in New York and Washington extends the dispute over cognitive claims for vitamin and supplement products from enforcement by FTC and FDA and questions from Congress to consumers' class action complaints.
You may also be interested in...
Cognitive Conditions Fueling Demand For Dietary Ingredient Breakthroughs
Rising rates of Alzheimer’s disease and other cognitive conditions fuel demand for brain health supplements among consumers, with more than a third of US consumers saying they would be “very likely” to take them for memory, according to research firm Natural Marketing Institute.
Avantius Launches Supplement After Study Finds Formulation Slowed Alzheimer’s Progression
Memory Health supplement was developed and is launching in the US after a small European study of Alzheimer’s patients finds improvement in patients taking a carotenoid/omega-3 combination, says marketer Avantius Group. A larger-scale, double blinded clinical study is underway in Europe.
NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call
NAD refers UltraMax Health's supplement claim to the FTC after it fails to provide substantiation. CRN emphasizes claims alone are not the problem, but the firm's failure to provide substantiation.